137 related articles for article (PubMed ID: 1302164)
41. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
Ferrari R; Ceconi C; Curello S; Pepi P; Mazzoletti A; Visioli O
Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():639-47. PubMed ID: 9115958
[TBL] [Abstract][Full Text] [Related]
42. The new trials: AIRE, ISIS-4, and GISSI-3. Is the dossier on ACE inhibitors and myocardial infarction now complete?
Opie LH
Cardiovasc Drugs Ther; 1994 Jun; 8(3):469-72. PubMed ID: 7947363
[TBL] [Abstract][Full Text] [Related]
43. A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E
Expert Opin Pharmacother; 2004 Sep; 5(9):1965-77. PubMed ID: 15330734
[TBL] [Abstract][Full Text] [Related]
44. The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
Sleight P
Curr Cardiol Rep; 2001 Nov; 3(6):511-8. PubMed ID: 11602083
[TBL] [Abstract][Full Text] [Related]
45. ACE for whom? Implications for clinical practice of post-infarct trials.
Walsh JT; Gray D; Keating NA; Cowley AJ; Hampton JR
Br Heart J; 1995 May; 73(5):470-4. PubMed ID: 7786664
[TBL] [Abstract][Full Text] [Related]
46. Potential role of angiotensin converting enzyme inhibitors in treatment of atherosclerosis.
Pitt B
Eur Heart J; 1995 Nov; 16 Suppl K():49-54. PubMed ID: 8869136
[TBL] [Abstract][Full Text] [Related]
47. ACE-inhibitor therapy after myocardial infarction--a new treatment strategy.
Hall AS; Ball SG
Z Kardiol; 1994; 83 Suppl 4():57-62. PubMed ID: 7856281
[TBL] [Abstract][Full Text] [Related]
48. [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease].
López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C; Priori SG; Alonso García MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Fernández Burgos E; Lekakis J; Lindahl B; Mazzotta G; McGregor K; Morais J; Oto A; Smiseth OA; Ardissino D; Avendano C; Blomström-Lundqvist C; Clément D; Drexler H; Ferrari R; Fox KA; Julian D; Kearney P; Klein W; Köber L; Mancia G; Nieminen M; Ruzillo W; Simoons M; Thygesen K; Tognoni G; Tritto I; Wallentin L; ;
Rev Esp Cardiol; 2004 Dec; 57(12):1213-32. PubMed ID: 15617645
[No Abstract] [Full Text] [Related]
49. Vasodilators after myocardial infarction-ISIS IV.
Sleight P
Am J Hypertens; 1994 Sep; 7(9 Pt 2):102S-105S. PubMed ID: 7818834
[TBL] [Abstract][Full Text] [Related]
50. Antiatherosclerotic effects of ACE inhibitors: where are we now?
Lonn E
Am J Cardiovasc Drugs; 2001; 1(5):315-20. PubMed ID: 14728013
[TBL] [Abstract][Full Text] [Related]
51. A vascular protective concept in hypertension and heart failure.
Bühler FR; Ball SG; Baumgartner HR; Ertem G; Ferrannini E; Goldstein S; Karpov YA; Kiowski W; Widmann T; Zanchetti A
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S1-4. PubMed ID: 7700058
[No Abstract] [Full Text] [Related]
52. Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
Sutton MS
Br Heart J; 1994 Feb; 71(2):115-8. PubMed ID: 8130017
[No Abstract] [Full Text] [Related]
53. Treatment of high-risk African American patients: left ventricular dysfunction, heart failure, renal disease, and postmyocardial infarction.
Arora R; Clark L; Taylor M
J Clin Hypertens (Greenwich); 2003; 5(1 Suppl 1):26-31. PubMed ID: 12556670
[TBL] [Abstract][Full Text] [Related]
54. Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease.
Halkin A; Keren G
Am J Med; 2002 Feb; 112(2):126-34. PubMed ID: 11835951
[TBL] [Abstract][Full Text] [Related]
55. ACE inhibitors in hypertension: a US perspective.
Dzau VJ
Cardiology; 1989; 76 Suppl 2():23-30. PubMed ID: 2670218
[TBL] [Abstract][Full Text] [Related]
56. [Enzyme converting inhibitors. Current knowledge and perspectives].
Pathé M
Presse Med; 1995 Dec; 24(38):1852-6. PubMed ID: 8545440
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of ACE/kininase-II, acute myocardial infarction, and survival.
Hall AS; Tan LB; Ball SG
Cardiovasc Res; 1994 Feb; 28(2):190-8. PubMed ID: 8143299
[TBL] [Abstract][Full Text] [Related]
58. Angiotensin-converting enzyme inhibition to enhance vascular health--clinical and research models.
Bakris GL
Am J Hypertens; 2001 Aug; 14(8 Pt 2):264S-269S. PubMed ID: 11497207
[TBL] [Abstract][Full Text] [Related]
59. ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study.
Ball SG; Hall AS; Murray GD
Eur Heart J; 1994 May; 15 Suppl B():20-5; discussion 26-30. PubMed ID: 8076659
[TBL] [Abstract][Full Text] [Related]
60. Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events.
MacMahon S; Chalmers J
Eur Heart J; 2003 Mar; 24(5):391-3. PubMed ID: 12633540
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
